Quanterix

Company Overview

Quanterix Corp. is a life sciences company that develops ultra-sensitive digital immunoassay platforms for life sciences research and diagnostics. Its platforms are based on its proprietary digital Simoa detection technology. The Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in extremely low concentrations in blood, serum and other fluids. Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology, which is the most widely used method of detection of proteins.

Its precision instruments, digital immunoassays and CLIA-certified Accelerator Laboratory environment support research that advances disease understanding and management in neurology, oncology, immunology, cardiology, and infectious disease. The company has commercialized assays that address approximately 154 protein biomarkers secreted or released in blood and CSF.

Simoa assays can detect neurological biomarkers, such as neurofilament light chain (NfL), Tau, GFAP and several others associated with brain injury and disease. Quanterix has a strategic focus in neurodegeneration, neuroinflammation, traumatic brain injuries (TBI) and multiple sclerosis (MS) and is working with a rapidly growing network of academic researchers and pharmaceutical and biotech partners to drive advances in head health research. Since the company commercially launched the first assay that could reliably measure NfL in blood using Uman’s antibodies and Simoa technology in 2017, NfL has seen dramatic growth as a neurological biomarker.

Financial Highlights (FY 2024)

Company's Business Segments

• Product Revenue : This segment includes Instruments, Consumable Products, Other Products.
• Service and Other Revenue : This segment includes Service-type Warranties, Research Services, Other Services.
• Collaboration and License Revenue : Collaboration and license revenues consist of licensing company Technology, Intellectual Property, Know-how Associated with instruments to Third Parties, for Related Services.
• Grant Revenue : Grant revenues consist of funding received to perform specific research and development services under grant arrangements.